Stohl W - Search Results

1

A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus.

Wallace DJ, Stohl W, Furie RA, Lisse JR, McKay JD, Merrill JT, Petri MA, Ginzler EM, Chatham WW, McCune WJ, Fernandez V, Chevrier MR, Zhong ZJ, Freimuth WW. Wallace DJ, et al. Among authors: stohl w. Arthritis Rheum. 2009 Sep 15;61(9):1168-78. doi: 10.1002/art.24699. Arthritis Rheum. 2009. PMID: 19714604 Free PMC article. Clinical Trial.

2

Impaired generation of polyclonal T cell-mediated cytolytic activity despite normal polyclonal T cell proliferation in systemic lupus erythematosus.

Stohl W. Stohl W. Clin Immunol Immunopathol. 1992 May;63(2):163-72. doi: 10.1016/0090-1229(92)90009-d. Clin Immunol Immunopathol. 1992. PMID: 1611718

3

Correlation between systemic lupus erythematosus and T4 epitope phenotype.

Stohl W, Singer JZ. Stohl W, et al. Arthritis Rheum. 1987 Dec;30(12):1412-5. doi: 10.1002/art.1780301213. Arthritis Rheum. 1987. PMID: 2449224

4

Impaired polyclonal T cell cytolytic activity. A possible risk factor for systemic lupus erythematosus.

Stohl W. Stohl W. Arthritis Rheum. 1995 Apr;38(4):506-16. doi: 10.1002/art.1780380408. Arthritis Rheum. 1995. PMID: 7718004

5

Impaired recovery and cytolytic function of CD56+ T and non-T cells in systemic lupus erythematosus following in vitro polyclonal T cell stimulation. Studies in unselected patients and monozygotic disease-discordant twins.

Stohl W, Elliott JE, Hamilton AS, Deapen DM, Mack TM, Horwitz DA. Stohl W, et al. Arthritis Rheum. 1996 Nov;39(11):1840-51. doi: 10.1002/art.1780391110. Arthritis Rheum. 1996. PMID: 8912506

6

Impaired nonrestricted cytolytic activity in systemic lupus erythematosus: involvement of a pathway independent of Fas, tumor necrosis factor, and extracellular ATP that is associated with little detectable perforin.

Stohl W, Elliott JE, Li L, Podack ER, Lynch DH, Jacob CO. Stohl W, et al. Arthritis Rheum. 1997 Jun;40(6):1130-7. doi: 10.1002/1529-0131(199706)40:6<1130::AID-ART17>3.0.CO;2-O. Arthritis Rheum. 1997. PMID: 9182924

7

Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases.

Cheema GS, Roschke V, Hilbert DM, Stohl W. Cheema GS, et al. Among authors: stohl w. Arthritis Rheum. 2001 Jun;44(6):1313-9. doi: 10.1002/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S. Arthritis Rheum. 2001. PMID: 11407690 Free article.

8

Systemic lupus erythematosus: a blissless disease of too much BLyS (B lymphocyte stimulator) protein.

Stohl W. Stohl W. Curr Opin Rheumatol. 2002 Sep;14(5):522-8. doi: 10.1097/00002281-200209000-00007. Curr Opin Rheumatol. 2002. PMID: 12192248 Review.

9

Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis.

Tan SM, Xu D, Roschke V, Perry JW, Arkfeld DG, Ehresmann GR, Migone TS, Hilbert DM, Stohl W. Tan SM, et al. Among authors: stohl w. Arthritis Rheum. 2003 Apr;48(4):982-92. doi: 10.1002/art.10860. Arthritis Rheum. 2003. PMID: 12687540 Free article.

10

SLE--systemic lupus erythematosus: a BLySful, yet BAFFling, disorder.

Stohl W. Stohl W. Arthritis Res Ther. 2003;5(3):136-8. doi: 10.1186/ar755. Epub 2003 Mar 27. Arthritis Res Ther. 2003. PMID: 12723979 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

161 results

Search Page